Alzheimer's And Aducanumab: Should Taxpayer Money Be Spent?
In 2019, Biogen announced that it was abandoning its late stage drug for Alzheimer’s, aducanumab but then in 2021 they got FDA approval for it.
More reads
Urea In Astronaut Pee Could Be Used To Build Moon Bases
I'm not all that excited about manned missions in space because it is a struggle for NASA to even build a space telescope without going 13 years over budget, but it's worth doing basic research on…
Brains Of Teenage Girls Who Engage In Cutting Are Similar To Those With Borderline Personality Disorder
A pilot study in Development and Psychopathology concluded that teenage girls who engage in self-harm like cutting often have brain features like adults with borderline personality disorder. Often is…
Inconsistency Of EV Battery Pack Performance Remains A Challenge
Electric cars are currently limited in utility, which means continued government subsidies and high cost, because battery technology has not changed in the last 35 years. When everything else in a…